Proposal to Accommodate Burkholderia Cepacia Genomovar VI As Burkholderia Dolosa Sp. Nov

Overview

Journal Int J Syst Evol Microbiol

Specialty Microbiology

Date 2004 May 15

PMID 15143009

Citations 36

Authors

Karen Vermis

Tom Coenye

John J LiPuma

Eshwar Mahenthiralingam

Hans J Nelis

Peter Vandamme

Affiliations

Soon will be listed here.

Abstract

Phenotypic and genotypic studies revealed new tools for differentiating Burkholderia cepacia genomovar VI from Burkholderia multivorans and other B. cepacia-complex species. Hence, the name Burkholderia dolosa sp. nov. is proposed, with LMG 18943(T) (=CCUG 47727(T)) as the type strain. B. dolosa can be differentiated from other B. cepacia-complex bacteria by its inability to assimilate tryptamine, azelaic acid and salicin and by its failure to grow on the B. cepacia-selective medium PCAT. Both 16S rDNA and recA RFLP analysis revealed unique B. dolosa restriction patterns. In addition, new 16S rDNA- and recA-based PCR assays allowed its specific identification.

Citing Articles

Twenty years of paradigm-breaking studies of taxonomy and symbiotic nitrogen fixation by beta-rhizobia, and indication of Brazil as a hotspot of Paraburkholderia diversity.

Paulitsch F, Dos Reis Jr F, Hungria M Arch Microbiol. 2021; 203(8):4785-4803.

PMID: 34245357 DOI: 10.1007/s00203-021-02466-5.

Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Tavares M, Kozak M, Balola A, Sa-Correia I Clin Microbiol Rev. 2020; 33(3).

PMID: 32295766 PMC: 7194853. DOI: 10.1128/CMR.00139-19.

Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans.

Wallner A, King E, Ngonkeu E, Moulin L, Bena G BMC Genomics. 2019; 20(1):803.

PMID: 31684866 PMC: 6829993. DOI: 10.1186/s12864-019-6186-z.

Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report.

Savi D, Quattrucci S, Trancassini M, Dalmastri C, De Biase R, Maggisano M BMC Pulm Med. 2019; 19(1):164.

PMID: 31464603 PMC: 6714384. DOI: 10.1186/s12890-019-0923-6.

Three Distinct Contact-Dependent Growth Inhibition Systems Mediate Interbacterial Competition by the Cystic Fibrosis Pathogen Burkholderia dolosa.

Perault A, Cotter P J Bacteriol. 2018; 200(22).

PMID: 30150233 PMC: 6199481. DOI: 10.1128/JB.00428-18.